Induces multifaceted immune responses including humoral (antibody) and T-cell responses. |
Inclusive of viral major surface glycoproteins, i.e., hemagglutinin and neuraminidase. Induces mostly antibody responses. |
Contains three times more HA than the standard inactivated influenza vaccine. It induces the production of anti-HA antibodies to prevent influenza virus infections. |
Licensed for use in recipients aged 2 years and older. |
Licensed for use in recipients aged 6 months and older. |
Licensed for use in adults aged 18 years old and older. |
Administered intranasally (mimicking natural infection). |
Administered intramuscularly. |
Administered intramuscularly. |